Media coverage
29
Media coverage
Title Protagonist Therapeutics Announces Updated Phase 2 Data Supporting Long-Term Efficacy of Rusfertide in Polycythemia Vera Media name/outlet Morningstar.com Country/Territory United States Date 11/06/21 URL https://www.morningstar.com/news/pr-newswire/20210611sf07863/protagonist-therapeutics-announces-updated-phase-2-data-supporting-long-term-efficacy-of-rusfertide-in-polycythemia-vera Persons Ronald Hoffman Title Protagonist Therapeutics Announces Updated Phase 2 Data Supporting Long-Term Efficacy of Rusfertide in Polycythemia Vera; Rusfertide demonstrated sustained hematocrit control, reversal of iron deficiency, and a reduction in phlebotomies, for up to 18 mont Media name/outlet PR Newswire Country/Territory United States Date 11/06/21 Persons Ronald Hoffman Title Protagonist Therapeutics Announces Updated Phase 2 Data Supporting Long-Term Efficacy of Rusfertide in Polycythemia Vera Media name/outlet ADVFN UK Country/Territory United Kingdom Date 11/06/21 URL https://uk.advfn.com/stock-market/NASDAQ/PTGX/share-news/Protagonist-Therapeutics-Announces-Updated-Phase-2/85340799 Persons Ronald Hoffman Title Protagonist Therapeutics Announces Updated Phase 2 Data Supporting Long-Term Efficacy of Rusfertide in Polycythemia Vera Media name/outlet Finanzen.net Country/Territory Germany Date 11/06/21 URL https://www.finanzen.net/nachricht/aktien/protagonist-therapeutics-announces-updated-phase-2-data-supporting-long-term-efficacy-of-rusfertide-in-polycythemia-vera-10230988 Persons Ronald Hoffman Title Protagonist Therapeutics Announces Updated Phase 2 Data Supporting Long-Term Efficacy of Rusfertide in Polycythemia Vera Media name/outlet Yahoo! Finance Country/Territory United States Date 11/06/21 URL https://finance.yahoo.com/news/protagonist-therapeutics-announces-updated-phase-110000527.html Persons Ronald Hoffman Title Protagonist Therapeutics Announces Updated Phase 2 Data Supporting Long-Term Efficacy of Rusfertide in Polycythemia Vera Media name/outlet Maryville Daily Times Country/Territory United States Date 11/06/21 URL https://www.thedailytimes.com/business/protagonist-therapeutics-announces-updated-phase-2-data-supporting-long-term-efficacy-of-rusfertide-in-polycythemia/article_88a60c0b-d3e6-5c3c-99af-3fcfdefc0a13.html Persons Ronald Hoffman Title Protagonist Therapeutics Announces Updated Phase 2 Data Supporting Long-Term Efficacy of Rusfertide in Polycythemia Vera Media name/outlet MicroSmallCap Country/Territory Canada Date 11/06/21 URL https://microsmallcap.com/protagonist-therapeutics-announces-updated-phase-2-data-supporting-long-term-efficacy-of-rusfertide-in-polycythemia-vera Persons Ronald Hoffman Title Protagonist Therapeutics : Announces Updated Phase 2 Data Supporting Long-Term Efficacy of Rusfertide in Polycythemia Vera Media name/outlet MarketScreener.com Country/Territory United States Date 11/06/21 URL https://www.marketscreener.com/quote/stock/PROTAGONIST-THERAPEUTICS-30494509/news/Protagonist-Therapeutics-nbsp-Announces-Updated-Phase-2-Data-Supporting-Long-Term-Efficacy-of-Rusf-35578935/ Persons Ronald Hoffman Title Protagonist Therapeutics Announces Updated Phase 2 Data Supporting Long-Term Efficacy of Rusfertide in Polycythemia Vera Media name/outlet TD Ameritrade Country/Territory United States Date 11/06/21 URL https://research.tdameritrade.com/grid/public/markets/news/story.asp?fromPage=results&docKey=100-162p7460 Persons Ronald Hoffman Title Protagonist Therapeutics Announces Updated Phase 2 Data Supporting Long-Term Efficacy of Rusfertide in Polycythemia Vera Media name/outlet Market Newsdesk Country/Territory United States Date 11/06/21 URL https://www.marketnewsdesk.com/index.php/protagonist-therapeutics-announces-updated-phase-2-data-supporting-long-term-efficacy-of-rusfertide-in-polycythemia-vera/ Persons Ronald Hoffman Title Protagonist Therapeutics Announces Updated Phase 2 Data Supporting Long-Term Efficacy of Rusfertide in Polycythemia Vera Media name/outlet Stockwatch Country/Territory Canada Date 11/06/21 URL www.stockwatch.com/News/Item/U-prSF07863-U!PTGX-20210611/U/PTGX Persons Ronald Hoffman Title Protagonist Therapeutics Announces Updated Phase 2 Data Supporting Long-Term Efficacy of Rusfertide in Polycythemia Vera Media name/outlet Crwe World Country/Territory United States Date 11/06/21 URL crweworld.com/article/news-provided-by-pr-newswire/2029044/protagonist-therapeutics-announces-updated-phase-2-data-supporting-long-term-efficacy-of-rusfertide-in-polycythemia-vera Persons Ronald Hoffman Title Protagonist Therapeutics Announces Updated Phase 2 Data Supporting Long-Term Efficacy of Rusfertide in Polycythemia Vera Media name/outlet ProfitQuotes.com Country/Territory United States Date 11/06/21 URL www.profitquotes.com/cgi/?a=news&ticker=a&w=&story=202106202106110700PR_NEWS_USPR_____SF07863 Persons Ronald Hoffman Title Protagonist Therapeutics Announces Updated Phase 2 Data Supporting Long-Term Efficacy of Rusfertide in Polycythemia Vera Media name/outlet Ariva.de Country/Territory Germany Date 11/06/21 URL www.ariva.de/news/protagonist-therapeutics-announces-updated-phase-2-data-9574117 Persons Ronald Hoffman Title Protagonist Therapeutics Announces Updated Phase 2 Data Supporting Long-Term Efficacy of Rusfertide in Polycythemia Vera Media name/outlet TickerTech.com Country/Territory United States Date 11/06/21 URL www.tickertech.com/cgi/?a=news&ticker=a&w=&story=202106202106110700PR_NEWS_USPR_____SF07863 Persons Ronald Hoffman Title Protagonist Therapeutics Announces Updated Phase 2 Data Supporting Long-Term Efficacy of Rusfertide in Polycythemia Vera Media name/outlet Finanzen.ch Country/Territory Switzerland Date 11/06/21 URL https://www.finanzen.ch/nachrichten/aktien/protagonist-therapeutics-announces-updated-phase-2-data-supporting-long-term-efficacy-of-rusfertide-in-polycythemia-vera-1030515255 Persons Ronald Hoffman Title Protagonist Therapeutics Announces Updated Phase 2 Data Supporting Long-Term Efficacy of Rusfertide in Polycythemia Vera Media name/outlet Spoke.com Country/Territory United States Date 11/06/21 URL https://www.spoke.com/press_releases/60c345322c33be4adb016bcc Persons Ronald Hoffman Title Protagonist Therapeutics Announces Updated Phase 2 Data Supporting Long-Term Efficacy of Rusfertide in Polycythemia Vera Media name/outlet BioSpace Country/Territory United States Date 11/06/21 URL https://www.biospace.com/article/releases/protagonist-therapeutics-announces-updated-phase-2-data-supporting-long-term-efficacy-of-rusfertide-in-polycythemia-vera/ Persons Ronald Hoffman Title Protagonist Therapeutics Announces Updated Phase 2 Data Supporting Long-Term Efficacy of Rusfertide in Polycythemia Vera Media name/outlet WFMZ-TV Online Country/Territory United States Date 11/06/21 URL https://www.wfmz.com/news/pr_newswire/pr_newswire_health/protagonist-therapeutics-announces-updated-phase-2-data-supporting-long-term-efficacy-of-rusfertide-in-polycythemia/article_50f26f10-5c83-5cb8-a1d5-94a4b0b97067.html Persons Ronald Hoffman Title Protagonist Therapeutics Announces Updated Phase 2 Data Supporting Long-Term Efficacy of Rusfertide in Polycythemia Vera Media name/outlet Bakersfield.com Country/Territory United States Date 11/06/21 URL https://www.bakersfield.com/ap/news/protagonist-therapeutics-announces-updated-phase-2-data-supporting-long-term-efficacy-of-rusfertide-in-polycythemia/article_03859276-0e67-5071-9046-aa667763585a.html Persons Ronald Hoffman Title Protagonist Therapeutics Announces Updated Phase 2 Data Supporting Long-Term Efficacy of Rusfertide in Polycythemia Vera Media name/outlet Elk Valley Times Country/Territory United States Date 11/06/21 URL https://www.elkvalleytimes.com/news/business/protagonist-therapeutics-announces-updated-phase-2-data-supporting-long-term-efficacy-of-rusfertide-in-polycythemia/article_25826f1a-9066-5676-aa4a-dce6738de5cc.html Persons Ronald Hoffman Title Protagonist Therapeutics Announces Updated Phase 2 Data Supporting Long-Term Efficacy of Rusfertide in Polycythemia Vera Media name/outlet Manchester Times Country/Territory United States Date 11/06/21 URL https://www.manchestertimes.com/news/business/protagonist-therapeutics-announces-updated-phase-2-data-supporting-long-term-efficacy-of-rusfertide-in-polycythemia/article_9b5d21f0-a7c9-5679-a1c6-d388bbe190f7.html Persons Ronald Hoffman Title Protagonist Therapeutics Announces Updated Phase 2 Data Supporting Long-Term Efficacy of Rusfertide in Polycythemia Vera Media name/outlet Citizen Tribune Country/Territory United States Date 11/06/21 URL https://www.citizentribune.com/news/business/protagonist-therapeutics-announces-updated-phase-2-data-supporting-long-term-efficacy-of-rusfertide-in-polycythemia/article_4a6dfd8a-a584-532d-96c1-fc8a8d4d21af.html Persons Ronald Hoffman Title Protagonist Therapeutics Announces Updated Phase 2 Data Supporting Long-Term Efficacy of Rusfertide in Polycythemia Vera Media name/outlet KPVI Country/Territory United States Date 11/06/21 URL https://www.kpvi.com/news/national_news/protagonist-therapeutics-announces-updated-phase-2-data-supporting-long-term-efficacy-of-rusfertide-in-polycythemia/article_2785f8fd-a2ee-5782-9d83-6293d65efbca.html Persons Ronald Hoffman Title Protagonist Therapeutics Announces Updated Phase 2 Data Supporting Long-Term Efficacy of Rusfertide in Polycythemia Vera Media name/outlet Tullahoma News Country/Territory United States Date 11/06/21 URL https://www.tullahomanews.com/news/business/protagonist-therapeutics-announces-updated-phase-2-data-supporting-long-term-efficacy-of-rusfertide-in-polycythemia/article_fc5a735c-5dad-5c31-bbf2-ecc7fb637f41.html Persons Ronald Hoffman Title Protagonist Therapeutics Announces Updated Phase 2 Data Supporting Long-Term Efficacy of Rusfertide in Polycythemia Vera Media name/outlet Desert Review Country/Territory United States Date 11/06/21 URL https://www.thedesertreview.com/news/state/protagonist-therapeutics-announces-updated-phase-2-data-supporting-long-term-efficacy-of-rusfertide-in-polycythemia/article_b90c2ac6-0787-548a-b76f-43d35f3f065e.html Persons Ronald Hoffman Title Protagonist Therapeutics Announces Updated Phase 2 Data Supporting Long-Term Efficacy of Rusfertide in Polycythemia Vera Media name/outlet Herald Chronicle Country/Territory United States Date 11/06/21 URL https://www.heraldchronicle.com/news/business/protagonist-therapeutics-announces-updated-phase-2-data-supporting-long-term-efficacy-of-rusfertide-in-polycythemia/article_1ebfeb47-87fc-5107-9856-2d89ba4b3089.html Persons Ronald Hoffman Title Protagonist Therapeutics Announces Updated Phase 2 Data Supporting Long-Term Efficacy of Rusfertide in Polycythemia Vera Media name/outlet Galveston County Daily News Country/Territory United States Date 11/06/21 URL https://www.galvnews.com/news_ap/business/article_5c702205-95d0-55d3-8243-e0b9ea9f6d45.html Persons Ronald Hoffman Title Protagonist Therapeutics Announces Updated Phase 2 Data Supporting Long-Term Efficacy of Rusfertide in Polycythemia Vera Media name/outlet Central Charts Country/Territory France Date 11/06/21 URL https://www.centralcharts.com/en/14077-protagonist-therapeutics-inc/news/3208236-protagonist-therapeutics-announces-updated-phase-2-data-supporting-long-term-efficacy-of-rusfertide-in-polycythemia-vera Persons Ronald Hoffman